NO983626D0 - Syntese av VIP-analog - Google Patents

Syntese av VIP-analog

Info

Publication number
NO983626D0
NO983626D0 NO983626A NO983626A NO983626D0 NO 983626 D0 NO983626 D0 NO 983626D0 NO 983626 A NO983626 A NO 983626A NO 983626 A NO983626 A NO 983626A NO 983626 D0 NO983626 D0 NO 983626D0
Authority
NO
Norway
Prior art keywords
synthesis
vip analog
analog
vip
relates
Prior art date
Application number
NO983626A
Other languages
English (en)
Norwegian (no)
Other versions
NO983626L (no
Inventor
David Robert Bolin
Waleed Danho
Arthur M Felix
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO983626L publication Critical patent/NO983626L/no
Publication of NO983626D0 publication Critical patent/NO983626D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Respiratory Apparatuses And Protective Means (AREA)
  • Regulating Braking Force (AREA)
  • Hydrogen, Water And Hydrids (AREA)
  • Catalysts (AREA)
  • Networks Using Active Elements (AREA)
  • Reduction Or Emphasis Of Bandwidth Of Signals (AREA)
NO983626A 1996-02-09 1998-08-07 Syntese av VIP-analog NO983626D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1142596P 1996-02-09 1996-02-09
PCT/EP1997/000380 WO1997029126A1 (fr) 1996-02-09 1997-01-29 Synthese d'analogue du peptide intestinal vasoactif (vip)

Publications (2)

Publication Number Publication Date
NO983626L NO983626L (no) 1998-08-07
NO983626D0 true NO983626D0 (no) 1998-08-07

Family

ID=21750320

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983626A NO983626D0 (no) 1996-02-09 1998-08-07 Syntese av VIP-analog

Country Status (15)

Country Link
US (2) US6080837A (fr)
EP (1) EP0879246B1 (fr)
JP (1) JP2000504676A (fr)
KR (1) KR100493795B1 (fr)
CN (1) CN1186355C (fr)
AT (1) ATE328004T1 (fr)
AU (1) AU722895B2 (fr)
BR (1) BR9707409A (fr)
CZ (1) CZ294779B6 (fr)
DE (1) DE69735991D1 (fr)
HU (1) HUP9900961A3 (fr)
MX (1) MX9806099A (fr)
NO (1) NO983626D0 (fr)
NZ (1) NZ330885A (fr)
WO (1) WO1997029126A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9707409A (pt) * 1996-02-09 1999-04-13 Waleed Danho Sintese de análogo de vip
FR2775902B1 (fr) * 1998-03-13 2001-05-11 Assist Publ Hopitaux De Paris Utilisation d'analogues du vip dans la prevention et le traitement des lesions cerebrales du nouveau-ne humain
US6281331B1 (en) * 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
NZ507083A (en) * 1998-03-23 2003-10-31 Trimeris Inc Methods and compositions for peptide synthesis, in particular T-20 (DP-178) and T-20-like peptides
WO2002043746A2 (fr) 2000-11-28 2002-06-06 Mondobiotech Sa Composes apparentes a l'activite biologique du peptide intestinal vasoactif pour le traitement de l'hypertension pulmonaire et arteriolaire
JP2005535607A (ja) 2002-06-10 2005-11-24 モンドバイオテック・ラボラトリーズ・アンスタルト サルコイドーシスを治療するための血管作動性腸管ペプチドの生物活性をもつ化合物の使用
KR100451432B1 (ko) * 2002-07-12 2004-10-06 강충경 T-20 펩타이드의 생물학적 제조방법
US20080085860A1 (en) * 2004-08-18 2008-04-10 Eli Lilly And Company Selective Vpac2 Receptor Peptide Agonists
WO2006023367A1 (fr) * 2004-08-18 2006-03-02 Eli Lilly And Company Agonistes peptidiques sélectifs du récepteur vpac2
BRPI0714306A2 (pt) * 2006-07-06 2014-05-20 Hoffmann La Roche Análogos do peptídio intestinal vasoativo
IN2012DN02120A (fr) 2009-08-14 2015-08-21 Phasebio Pharmaceuticals Inc
ES2669190T3 (es) 2011-06-06 2018-05-24 Phasebio Pharmaceuticals, Inc. Uso de péptidos intestinales vasoactivos modificados en el tratamiento de la hipertensión
ES2822598T3 (es) 2015-02-09 2021-05-04 Phasebio Pharmaceuticals Inc Métodos y composiciones para tratar enfermedades y trastornos musculares
CN110317257B (zh) * 2019-06-03 2023-10-31 吉尔生化(上海)有限公司 一种辛卡利特的固液相合成法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237046A (en) * 1979-04-27 1980-12-02 Miklos Bodanszky Polypeptides and methods of preparation
AU6446190A (en) * 1989-09-15 1991-04-18 Rutgers, The State University Of New Jersey Process for inducing analgesia, peptides and therapeutic compositions
AU656230B2 (en) * 1991-10-11 1995-01-27 F. Hoffmann-La Roche Ag Cyclic vasoactive peptides
JPH0616694A (ja) * 1992-07-01 1994-01-25 Sato Seiyaku Kk カルシトニンの製造法
ES2051647B1 (es) * 1992-12-10 1995-01-16 Lipotec Sa Procedimiento para la preparacion de calcitonina de salmon.
BR9707409A (pt) * 1996-02-09 1999-04-13 Waleed Danho Sintese de análogo de vip

Also Published As

Publication number Publication date
DE69735991D1 (de) 2006-07-06
MX9806099A (es) 1998-10-31
AU1596397A (en) 1997-08-28
HUP9900961A3 (en) 2001-06-28
US6080837A (en) 2000-06-27
KR19990082403A (ko) 1999-11-25
CZ294779B6 (cs) 2005-03-16
AU722895B2 (en) 2000-08-10
HUP9900961A2 (hu) 1999-07-28
EP0879246A1 (fr) 1998-11-25
KR100493795B1 (ko) 2005-09-09
BR9707409A (pt) 1999-04-13
NO983626L (no) 1998-08-07
EP0879246B1 (fr) 2006-05-31
CN1210543A (zh) 1999-03-10
ATE328004T1 (de) 2006-06-15
CZ251698A3 (cs) 1998-11-11
US6316593B1 (en) 2001-11-13
WO1997029126A1 (fr) 1997-08-14
JP2000504676A (ja) 2000-04-18
NZ330885A (en) 2000-02-28
CN1186355C (zh) 2005-01-26

Similar Documents

Publication Publication Date Title
NO983626L (no) Syntese av VIP-analog
DE69623996D1 (de) Hydrozyklon zur gastrennung
AUPP616498A0 (en) Synthesis of cyclic peptides
NO974378D0 (no) Fremgangsmåte til behandling av gasser
NO960497L (no) Dobbelt kolonneprosess for fjerning av nitrogen fra naturgass
TR199600608A2 (tr) Azotun diger gazlardan adsorpsiyonla ayrilmasi.
NO20001315L (no) Separasjon av sure gasser fra gassblandinger
HUP9802372A3 (en) Cyclic peptide analogs of somatostatin
DE69515068D1 (de) Atmospherisches Gastrennungsverfahren
ZA972890B (en) Production of synthesis gas from hydrocarbonaceous feedstock.
DE69935313D1 (de) Nachweisverfahren für peptide
GB9523517D0 (en) Separation of gases
MX9801190A (es) Inhibidores de prolil endopeptidasa.
DE69626462T2 (de) Herstellung von Gas
EP0831878A4 (fr) Nouveaux inhibiteurs peptidiques de la calmoduline
BR9700898A (pt) Secção de linha de uma linha isolada a gás
BG103649A (en) Method for the preparation of eprosartan
EP0728999A3 (fr) Séparation de mélanges gazeux
TR199600932T1 (tr) Yeni peptidlerin bagisiklik düzenleyici (immünomodülatör)etkileri.
AU4095596A (en) Purification of natural gas
ZA974765B (en) Process for the production of gas
AU2061897A (en) Separation of calcium from metal compounds
ID18722A (id) Proses pemisahan ketoksim atau aldoksim dari amida
IL118300A0 (en) Method for the purification of chlorine gas
ZA967972B (en) Cyclic peptide analogs of somatostatin

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application